193 related articles for article (PubMed ID: 1133171)
1. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus.
DeHoratius RJ; Messner RP
J Clin Invest; 1975 Jun; 55(6):1254-8. PubMed ID: 1133171
[TBL] [Abstract][Full Text] [Related]
2. Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.
DeHoratius RJ; Pillarisetty R; Messner RP; Talal N
J Clin Invest; 1975 Nov; 56(5):1149-54. PubMed ID: 1081099
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of anti-lymphocyte antibodies in systemic lupus erythematosus.
Messner RP; De Horatius RJ
Arthritis Rheum; 1978 Jun; 21(5 Suppl):S167-70. PubMed ID: 666880
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytotoxic antibodies in mexican patients with systemic lupus erythematosus and their families relationship of disease activity in the probands to antibody cytotoxicity in their relatives.
DeHoratius RJ; Alarcón-Segovia D; Messner RP; Fishbein E
Rev Invest Clin; 1981; 33(2):161-4. PubMed ID: 7291760
[No Abstract] [Full Text] [Related]
5. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytotoxic antibody in inflammatory bowel disease. A family study.
Korsmeyer SJ; Williams RC; Wilson ID; Strickland RG
N Engl J Med; 1975 Nov; 293(22):1117-20. PubMed ID: 1186774
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
van der Linden MW; Westendorp RG; Zidane M; Meheus L; Huizinga TW
J Rheumatol; 2001 Feb; 28(2):284-7. PubMed ID: 11246662
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of systemic autoimmune disorders & autoantibodies in house-hold contacts of patients with systemic lupus erythematosus.
Aggarwal A; Singh RR; Kumar A; Misra R; Malaviya AN
Indian J Med Res; 1991 Apr; 94():96-8. PubMed ID: 1879893
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus & their household contacts.
Vasan RS; Mehra NK; Malaviya AN; Chaudhuri TK
Indian J Med Res; 1990 Jun; 92():147-50. PubMed ID: 2401534
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus.
Ooi BS; Orlina AR; Pesce AJ; Mendoza N; Masaitis L; Pollak VE
Clin Exp Immunol; 1974 Jun; 17(2):237-43. PubMed ID: 4466602
[TBL] [Abstract][Full Text] [Related]
11. Antilymphocyte antibodies in systemic lupus erythematosus: familial clustering of lymphocyte antigens.
Persselin JE; Messner RP; DeHoratius RJ; Troup GM
J Rheumatol; 1977; 4(1):11-4. PubMed ID: 301939
[TBL] [Abstract][Full Text] [Related]
12. Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement.
Bresnihan B; Oliver M; Grigor R; Hughes GR
Clin Exp Immunol; 1977 Dec; 30(3):333-7. PubMed ID: 606449
[TBL] [Abstract][Full Text] [Related]
13. Relation between lymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA antibody idiotype PR4 in patients with systemic lupus erythematosus, their relatives and spouses.
Le Page SH; Williams W; Parkhouse D; Cambridge G; MacKenzie L; Lydyard PM; Isenberg DA
Clin Exp Immunol; 1989 Sep; 77(3):314-8. PubMed ID: 2805403
[TBL] [Abstract][Full Text] [Related]
14. Purification of antilymphocyte antibody (ALA) from patients with systemic lupus erythematosus (SLE)-immunoabsorption and elution.
Yamana S; Nakamura Z; Saito Y; Yamamoto M; Ofuji T
Acta Med Okayama; 1979 Aug; 33(4):259-67. PubMed ID: 91309
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of monocyte reactive antibodies on monocyte chemotaxis in systemic lupus erythematosus.
Szegedi G; Lukács K; Bodolay E; Gulácsi L; Sonkoly I; Szabó G; Szöllösi J
Haematologia (Budap); 1985; 18(3):175-83. PubMed ID: 3836156
[TBL] [Abstract][Full Text] [Related]
17. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families.
Gröndal G; Kristjansdottir H; Gunnlaugsdottir B; Arnason A; Lundberg I; Klareskog L; Steinsson K
Arthritis Rheum; 1999 Aug; 42(8):1649-54. PubMed ID: 10446864
[TBL] [Abstract][Full Text] [Related]
18. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.
Miller KB; Schwartz RS
N Engl J Med; 1979 Oct; 301(15):803-9. PubMed ID: 314587
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives: reactivity with the HLA antigenic molecular complex.
Messner RP; De Horatius R; Ferrone S
Arthritis Rheum; 1980 Mar; 23(3):265-72. PubMed ID: 6153898
[TBL] [Abstract][Full Text] [Related]
20. Antibodies for T lymphocytes in systemic lupus erythematosus.
Michlmayr G; Pathouli C; Huber C; Huber H
Clin Exp Immunol; 1976 Apr; 24(1):18-25. PubMed ID: 1084815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]